Key facts
- This page summarizes Gail R. Wilensky's Form 4 filing for QUEST DIAGNOSTICS INC (DGX).
- 1 reported transaction and 0 derivative rows are listed below.
- Accepted by SEC: 19 May 2023, 18:17.
Gail R. Wilensky - 17 May 2023 Form 4 Insider Report for QUEST DIAGNOSTICS INC (DGX)
- Reporting relationship
- Director
- Issuer ticker
- DGX
- Reported as of
- 17 May 2023
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 19 May 2023, 18:17:44 UTC
- Prior SEC filing
- 04 Jan 2023
- Source filing
- View source filing
- Reporting owner signature
- Sean D. Mersten, Attorney in Fact for Gail R. Wilensky
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
Gail R. Wilensky filed Form 4 for QUEST DIAGNOSTICS INC (DGX) on 19 May 2023.
Change
- Previous filing in this sequence was filed on 04 Jan 2023.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
DGX
transaction
Common Stock
Award
- Transaction value
- $0
- Shares
- +1,369
- Change %
- +7.2%
- Price
- $0.000000
- Shares after
- 20,506
- Date
- 17 May 2023
- Ownership
- Direct
- Footnotes
- F1
DGX
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 13,375
- Date
- 17 May 2023
- Ownership
- by Trust
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
Represents an award of restricted stock units.